Phase I Study of Lapatinib (GW572016) in Combination With Weekly Ixabepilone (BMS 247550) in Advanced Solid Tumors.

Trial Profile

Phase I Study of Lapatinib (GW572016) in Combination With Weekly Ixabepilone (BMS 247550) in Advanced Solid Tumors.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 27 Mar 2012

At a glance

  • Drugs Lapatinib (Primary) ; Ixabepilone
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Mar 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 27 Mar 2012 Actual patients number (5) added as reported by ClinicalTrials.gov.
    • 27 Mar 2012 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top